Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2005
12/21/2005EP1605946A2 Thiazoles useful as inhibitors of protein kinases
12/21/2005EP1605945A1 Topical formulation and use of buspirone
12/21/2005EP1605944A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists
12/21/2005EP1605942A1 Regimen of administration for nelfinavir
12/21/2005EP1605940A1 METHOD FOR TREATING MILD COGNITIVE IMPAIRMENT AND FOR PREVENTING OR DELAYING ALZHEIMER’S DISEASE
12/21/2005EP1605939A1 Pharmaceutical use of 1-azabicyclo[ 2.2.2] octanes and a method of testing compounds for the ability of activating inactive wt p53
12/21/2005EP1605938A2 Antibacterial agents
12/21/2005EP1605937A1 Treatment of proliferative diseases with epothilone derivatives and radiation
12/21/2005EP1605935A2 Methods of using and compositions comprising selective cytokine inhibitory drugs for the treatment and management of disorders of the central nervous system
12/21/2005EP1605933A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5- methyl-n-cycloalkyl-2-pyrrolidone by reductive amination of levulinic acid with aryl amines
12/21/2005EP1605932A1 Intranasal formulation of rotigotine
12/21/2005EP1605931A1 Drug formulations having long and medium chain triglycerides
12/21/2005EP1605930A1 Use of arachidonic acid for normalization of infradian rhythm
12/21/2005EP1605929A1 Non-steroidal anti-inflammatory drug dosing regimen
12/21/2005EP1605928A1 Compositions and methods for treatment of premature ejaculation
12/21/2005EP1605927A1 Anti-microbially active diamine-based guanine derivatives
12/21/2005EP1605926A1 Use of pinitol or chiroinositol for protecting the liver
12/21/2005EP1605925A1 Treatment of type 1 diabetes with pde5 inhibitors
12/21/2005EP1605924A2 Mesoprogestins (progesterone receptor modulators) as a component of compositions for hormone replacement therapy (hrt)
12/21/2005EP1605922A2 Temporary embolization using inverse thermosensitive polymers
12/21/2005EP1605921A1 Formulations comprising an active ingredient and cocoa powder and use thereof
12/21/2005EP1605920A1 Formulations comprising tolterodine and cocoa powder and use thereof
12/21/2005EP1605919A1 Stable pharmaceutical composition of rabeprazole and processes for their preparation
12/21/2005EP1605916A1 Solvent system of hardly soluble drug with improved elution rate
12/21/2005EP1605914A1 Method for preparing small particles
12/21/2005EP1605913A2 Angiogenesis promotion by prostaglandin compositions and methods
12/21/2005EP1605912A2 Preserved ophthalmic compositions
12/21/2005EP1605911A2 Office products containing antimicrobial agent
12/21/2005EP1605901A2 Selectively inhibiting estrogen production and providing estrogenic effects in the human body
12/21/2005EP1605900A2 Use of benzyl alcohol, and other phenolic preservatives to reduce pain during intradermal injection
12/21/2005EP1605897A2 Polyethelene glycol link glp-1 compounds
12/21/2005EP1605896A2 7-amino- isoindolyl compounds amd their pharmaceutical uses
12/21/2005EP1605895A2 Oral insulin therapies and protocol
12/21/2005EP1605892A2 Combination of an aldosterone receptor antagonist and an anti-diabetic agent
12/21/2005EP1605890A1 Kit for pharmaceutical use
12/21/2005EP1605782A1 Comestibles containing isomaltulose and trehalose for sustained carbohydrate energy release and reduced glycemic/insulinemic responses, and for preserving osmolality
12/21/2005EP1605776A1 Method and composition for preventing or reducing diarrhea
12/21/2005EP1605768A2 Lipid-improving agent and composition containing lipid-improvimg agent
12/21/2005EP1605764A2 Composition and method for appetite and carvingsuppressission and mood enhancement
12/21/2005EP1605756A2 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid esters with aryl and alkyl amines
12/21/2005EP1605755A2 Production of n-aryl-2-lactam and n-alkyl-2-lactam by reductive amination of lactones with aryl and alkyl nitro compounds
12/21/2005EP1605754A1 Production of 5-methyl-n-aryl-2-pyrrolidone and 5-methyl-n-alkyl-2-pyrrolidone by reductive amination of levulinic acid with nitro compounds
12/21/2005EP1605753A2 Production of n-aryl-2-lactam and n-cycloalkyl-2-lactam by reductive amination of lactones with aryl amines
12/21/2005EP1605752A1 Compounds, compositions and methods
12/21/2005EP1603451A3 Amyloid plaque as a target for therapeutics that function by blocking or disrupting chitin synthesis or activity
12/21/2005EP1490391B1 19-nor-17alpha-pregna-1,3,5(10)-trien-17beta-ols with a 21,16alpha-lactone ring substituted with a long chain at the 11beta position
12/21/2005EP1465898B1 Biocidal compounds and their preparation
12/21/2005EP1465665B1 Water-soluble stabilized self-assembled polyelectrolytes
12/21/2005EP1463728A4 Fused cyclic modulators of nuclear hormone receptor function
12/21/2005EP1458723A4 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
12/21/2005EP1432701B1 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
12/21/2005EP1429780B1 Method of treating middle ear infections
12/21/2005EP1395558B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1395555B1 4-(phenyl-(piperidin-4-yl)-amino)-benzamide derativatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
12/21/2005EP1389205B1 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders
12/21/2005EP1377567B1 Quinoline-4-carboxamide derivatives as nk-3 and nk-2 receptor antagonists
12/21/2005EP1373366B1 Multi-arm block copolymers and pharmaceutical compositions
12/21/2005EP1363897B1 Antagonists of mcp-1 function and methods of use thereof
12/21/2005EP1362039B1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
12/21/2005EP1313738B1 Process for the preparation and purification of thiol-containing maytansinoids
12/21/2005EP1313464A4 Method for treatment of reactive arthritis or bursitis
12/21/2005EP1307445B1 Benzofuran derivatives and their use as antibacterial agents
12/21/2005EP1286674A4 Methods and compositions for potentiating cancer chemotherapeutic agents
12/21/2005EP1282429A4 Pharmaceutical gel composition
12/21/2005EP1282402B1 Stabilized aqueous suspensions for parenteral use
12/21/2005EP1278759B1 Bis-(n,n'-bis-(2-haloethyl)amino) phosphoramidates as antitumor agents
12/21/2005EP1278730B1 4-benzyl-1-[2-(4-hydroxy-phenoxy)-ethyl]-piperidine-3,4-diol
12/21/2005EP1265930A4 Cyclodextrin dimers with spacers having peptide structures for encapsulation of pharmaceutically active substances with potential high side-effects
12/21/2005EP1265859B1 Amidino compounds useful as nitric oxide synthase inhibitors
12/21/2005EP1223915B1 Dry powder compositions having improved dispersivity
12/21/2005EP1196160B1 A synergistic combination: gabapentin and pregabalin
12/21/2005EP1178973B1 Pyrazinyl-piperazine- compounds, their use and preparation
12/21/2005EP1144431B1 16-hydroxyestratrienes as selective estrogens
12/21/2005EP1125924B1 Intermediate for the synthesis of amlodipine, preparation process and corresponding utilization
12/21/2005EP1104436B1 Beta-l-2'-deoxy-nucleosides for the treatment of hepatitis b virus
12/21/2005EP1102768B1 Substituted pyrazole derivatives condensed with six-membered heterocyclic rings
12/21/2005EP1066038B1 Use of cabergoline in the treatment of restless legs syndrome
12/21/2005EP1027058B1 Disaccharide derivatives for treating hyperglycaemia
12/21/2005EP1023059B1 Pharmaceutical preparations
12/21/2005EP0975766B1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
12/21/2005EP0831807B1 Use of brefeldin a and derivatives thereof in the preparation of medicaments for the treatment of hyperplasia and related disorders
12/21/2005EP0809705B1 Nucleic acid-containing composition, preparation and use thereof
12/21/2005EP0785772A4 Lyophilizate of lipid complex of water insoluble camptothecins
12/21/2005EP0777474B1 Methods for the treatment of inflammatory joint disease
12/21/2005EP0713393B1 Estrogenic compounds as anti-angiogenesis agents
12/21/2005EP0698108B2 Adenoviral vectors of animal origin and use thereof in gene therapy
12/21/2005EP0579819B1 Novel pyridone derivative having an affinity for the angiotensine ii receptor
12/21/2005CN1711284A Isolating chondroitin sulfate
12/21/2005CN1711265A Novel amino-substituted dihydropyrimido[4,5-d]pyrimidinone derivatives, their manufacture and use as pharmaceutical agents
12/21/2005CN1711258A Pyrimidine compounds
12/21/2005CN1711256A 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
12/21/2005CN1711252A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711251A 4(phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain or gastrointestinal disorders
12/21/2005CN1711248A Pyrimidine-sulfamides and their use as endothelian receptor antagonist
12/21/2005CN1711107A Remedy for glaucoma comprising Rho kinase inhibitor and beta-blocker
12/21/2005CN1711100A Cyclooxygenase-2 inhibitory withanolide compositions and method
12/21/2005CN1711095A Composition for restoring damaged skin
12/21/2005CN1711094A Combination product of inhibitor of the SRC family of non-receptor tyrosine kinases and gemcitabine
12/21/2005CN1711093A Process to minimize loss through adhesion to equipment surfaces
12/21/2005CN1711092A The use of an anti-allergy agent and a steroid to treat allergic rhinitis
1 ... 4428 4429 4430 4431 4432 4433 4434 4435 4436 4437 4438 4439 4440 4441 4442 4443 4444 4445 4446 4447 4448 ... 7860